Evolva updates financial guidance
February 18, 2013 | by Evolva SA
Reading time: 1 minute
February 18, 2013, Evolva Holding SA today updated its financial guidance of November 2012. Based on preliminary, unaudited accounts, revenues were approximately CHF 7 million in 2012 (2011: CHF 11.1 million) and the cash position at year-end 2012 amounted to approximately CHF 10 million (of which 1 million was restricted), in line with the guidance in November 2012. The financial report for 2012 will be published on 9 April 2013.
For 2013, Evolva maintains its expectation of a significant increase in revenues from the level achieved in 2012, and now guides that these are expected to be in the CHF 10-13 million range.
Evolva also announces that Norbert Bender, Chief Medical Officer, will be taking up a position at another company with effect from 1 June 2013. Dr. Bender joined Evolva in May 2011 after working as a medical consultant to the company since October 2010.
Neil Goldsmith, Chief Executive Officer of Evolva, said: “We would like to thank Norbert for his contribution to Evolva to date, and wish him well in his new position. In line with its strategy of focusing on ingredients for health, wellness and nutrition, the Company does not currently contemplate hiring a replacement.”
Media Contact:
Paul Verbraeken Investor Relations E-mail: paulv@evolva.com Direct phone: + 41 61 485 2035 Mobile: + 41 79 739 2636
Editor's note: Image rights belong to the respective publisher.
Conclusion of this article: « Evolva updates financial guidance »
Source: Evolva SA , Press release